Luc Therapeutics
-
2010
Company Description
Luc Therapeutics is developing novel therapeutics targeting the NMDA receptor to treat neuropsychiatric disorders.
Luc Therapeutics is developing novel therapeutics targeting the NMDA receptor to treat neuropsychiatric disorders. NMDA receptors are essential components of the brain's cognitive engine, dynamic synaptic plasticity. Luc Therapeutics was formerly known as Mnemosyne Pharmaceuticals.
-
Manufacturer:
Science and Engineering -
Formed:
2010 -
Company Website:
-
Company E-mail:
-
Company Address:
400 Technology Square 10th FloorCambridge, MAUnited States -
CEO:
- Robert A Volkmann
-
We recognize our sponsors starting at $1 per entry.
Learn more at https://www.ithistory.org/benefits